DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities
Abstract Therapies targeting RNA are rapidly expanding, with 24 FDA-approved RNA therapeutics and over 130 currently in clinical trials, highlighting RNA’s growing role in drug discovery. In this context, transformer-based language models provide a scalable and cost-effective approach to accelerate RNA-targeted drug di...